跳至主要内容
临床试验/TCTR20210510002
TCTR20210510002尚未招募3 期

A prospective cohort study of nutritional status and uremic toxin removal during long-term periods of super high-flux hemodialysis in chronic hemodialysis patients and the effect of RNA sequencing on peripheral blood mononuclear cells

Faculty of medicine, Naresuan University0 个研究点目标入组 15 人开始时间: 2021年5月10日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Years 至 90 Years(—)
性别
All

入选标准

  • Age > 18 years old
  • Prevalence case of hemodialysis at least 3 months
  • Hemodialysis 3 times/week with adequate Kt/V > 1.2
  • Serum albumin > 3 mg/dL
  • Vascular access are eligible for blood flow rate > 400 ml/min
  • Adequate dry weight with BCM +/- OH 2 kg
  • Hemodynamic stability more than 2 weeks
  • Inform consent

排除标准

  • Chronic infection or active cardiovascular diseases 3 month prior to recruitment
  • Metastasis malignancy
  • Advance cirrhosis
  • Hemodynamic instability
  • Contraindication to anticoagulant
  • Refuse to informed consent
  • Serum albumin levels < 3 mg/d

研究者

发起方
Faculty of medicine, Naresuan University

相似试验